Interplay of Oncoplastic Reconstruction and Adjuvant Radiation Therapy in Breast Cancer

Purpose: Oncoplastic breast surgery (OBS) combines breast cancer tumor removal with the cosmetic benefits of plastic surgery at the time of breast-conserving surgery. Potential advantages of OBS include wider surgical margins around the tumor bed, while the natural shape and appearance of the breast...

Full description

Bibliographic Details
Main Authors: Ryan T. Morse, MD, Matthew Moreno, MD, James A. Butterworth, MBBCh, FACS, Melissa P. Mitchell, MD, PhD
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109423002312
_version_ 1827382495068291072
author Ryan T. Morse, MD
Matthew Moreno, MD
James A. Butterworth, MBBCh, FACS
Melissa P. Mitchell, MD, PhD
author_facet Ryan T. Morse, MD
Matthew Moreno, MD
James A. Butterworth, MBBCh, FACS
Melissa P. Mitchell, MD, PhD
author_sort Ryan T. Morse, MD
collection DOAJ
description Purpose: Oncoplastic breast surgery (OBS) combines breast cancer tumor removal with the cosmetic benefits of plastic surgery at the time of breast-conserving surgery. Potential advantages of OBS include wider surgical margins around the tumor bed, while the natural shape and appearance of the breast are maintained more than standard lumpectomy procedures. However, limited information is available regarding the potential effect on adjuvant radiation treatment planning. Materials and Methods: Women with localized breast cancer undergoing lumpectomy with immediate OBS and adjuvant radiation therapy between 2014 and 2019 were reviewed. OBS was performed using volume displacement techniques and patients received whole-breast irradiation with 3-dimensional conformal radiation therapy. Results: Volume of additional ipsilateral breast tissue removed during OBS ranged from 21 to 2086 cm3 (median, 304 cm3), 29% of patients had >500 cm3 of tissue removed. Surgical margins were positive in 12.5% and were not affected by volume of breast tissue removed (445 vs 439 cm3). Patients with surgical clips more often received a lumpectomy bed boost (75.9% vs 50.0%), boost volumes were on average 157 cm3 with clips versus 205 cm3 without clips. Mean V105 was comparable in patients with >500 cm3 tissue removed and irradiated breast volume >1000 cm3, while higher absolute volumes were found in patients with >26 cm posterior separation (58.0 cm3 vs 102.7 cm3; P = .07). No meaningful difference was observed in Dmax or radiation coverage (95% of the volume receiving 95% of the prescription dose) for patients with >26 cm posterior separation, >500 cm3 of breast tissue removed, or irradiated breast volume >1000 cm3. Conclusions: Radiation dosimetry plans for patients undergoing oncoplastic surgery were acceptable and no significant radiation or surgical advantage was gained in patients with more tissue removed. Our study stresses the importance of clear communication between surgeons and radiation oncologists about sufficient marking of the lumpectomy cavity, using practices that minimize the need for re-excisions and minimize lumpectomy cavity disruption during rearrangement.
first_indexed 2024-03-08T14:21:30Z
format Article
id doaj.art-b585940518d44ad18a025524adfe7af1
institution Directory Open Access Journal
issn 2452-1094
language English
last_indexed 2024-03-08T14:21:30Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Advances in Radiation Oncology
spelling doaj.art-b585940518d44ad18a025524adfe7af12024-01-14T05:39:40ZengElsevierAdvances in Radiation Oncology2452-10942024-03-0193101403Interplay of Oncoplastic Reconstruction and Adjuvant Radiation Therapy in Breast CancerRyan T. Morse, MD0Matthew Moreno, MD1James A. Butterworth, MBBCh, FACS2Melissa P. Mitchell, MD, PhD3Department of Radiation Oncology, University of North Carolina Chapel Hill, Chapel Hill, North Carolina; Corresponding author: Ryan Morse, MDDepartment of Plastic Surgery, University of Kansas Medical Center, Kansas City, KansasDepartment of Plastic Surgery, University of Kansas Medical Center, Kansas City, KansasDepartment of Radiation Oncology, UT—MD Anderson Cancer Center, Houston, TexasPurpose: Oncoplastic breast surgery (OBS) combines breast cancer tumor removal with the cosmetic benefits of plastic surgery at the time of breast-conserving surgery. Potential advantages of OBS include wider surgical margins around the tumor bed, while the natural shape and appearance of the breast are maintained more than standard lumpectomy procedures. However, limited information is available regarding the potential effect on adjuvant radiation treatment planning. Materials and Methods: Women with localized breast cancer undergoing lumpectomy with immediate OBS and adjuvant radiation therapy between 2014 and 2019 were reviewed. OBS was performed using volume displacement techniques and patients received whole-breast irradiation with 3-dimensional conformal radiation therapy. Results: Volume of additional ipsilateral breast tissue removed during OBS ranged from 21 to 2086 cm3 (median, 304 cm3), 29% of patients had >500 cm3 of tissue removed. Surgical margins were positive in 12.5% and were not affected by volume of breast tissue removed (445 vs 439 cm3). Patients with surgical clips more often received a lumpectomy bed boost (75.9% vs 50.0%), boost volumes were on average 157 cm3 with clips versus 205 cm3 without clips. Mean V105 was comparable in patients with >500 cm3 tissue removed and irradiated breast volume >1000 cm3, while higher absolute volumes were found in patients with >26 cm posterior separation (58.0 cm3 vs 102.7 cm3; P = .07). No meaningful difference was observed in Dmax or radiation coverage (95% of the volume receiving 95% of the prescription dose) for patients with >26 cm posterior separation, >500 cm3 of breast tissue removed, or irradiated breast volume >1000 cm3. Conclusions: Radiation dosimetry plans for patients undergoing oncoplastic surgery were acceptable and no significant radiation or surgical advantage was gained in patients with more tissue removed. Our study stresses the importance of clear communication between surgeons and radiation oncologists about sufficient marking of the lumpectomy cavity, using practices that minimize the need for re-excisions and minimize lumpectomy cavity disruption during rearrangement.http://www.sciencedirect.com/science/article/pii/S2452109423002312
spellingShingle Ryan T. Morse, MD
Matthew Moreno, MD
James A. Butterworth, MBBCh, FACS
Melissa P. Mitchell, MD, PhD
Interplay of Oncoplastic Reconstruction and Adjuvant Radiation Therapy in Breast Cancer
Advances in Radiation Oncology
title Interplay of Oncoplastic Reconstruction and Adjuvant Radiation Therapy in Breast Cancer
title_full Interplay of Oncoplastic Reconstruction and Adjuvant Radiation Therapy in Breast Cancer
title_fullStr Interplay of Oncoplastic Reconstruction and Adjuvant Radiation Therapy in Breast Cancer
title_full_unstemmed Interplay of Oncoplastic Reconstruction and Adjuvant Radiation Therapy in Breast Cancer
title_short Interplay of Oncoplastic Reconstruction and Adjuvant Radiation Therapy in Breast Cancer
title_sort interplay of oncoplastic reconstruction and adjuvant radiation therapy in breast cancer
url http://www.sciencedirect.com/science/article/pii/S2452109423002312
work_keys_str_mv AT ryantmorsemd interplayofoncoplasticreconstructionandadjuvantradiationtherapyinbreastcancer
AT matthewmorenomd interplayofoncoplasticreconstructionandadjuvantradiationtherapyinbreastcancer
AT jamesabutterworthmbbchfacs interplayofoncoplasticreconstructionandadjuvantradiationtherapyinbreastcancer
AT melissapmitchellmdphd interplayofoncoplasticreconstructionandadjuvantradiationtherapyinbreastcancer